Skip to contentMITCHELL KATE — Fortive Corp insider: 98 transactions · InsiderLensMITCHELL KATE
- 10% owner at ALIMERA SCIENCES INC · on record since Apr 28, 2010
- 10% owner at Somaxon Pharmaceuticals, Inc. · on record since Jul 9, 2009
- Director at SVB FINANCIAL GROUP · on record since Apr 29, 2010
- 10% owner at ZOGENIX, INC. · on record since Nov 29, 2010
- 10% owner at HORIZON PHARMA, INC. · on record since Jul 28, 2011
- Former 10% Holder at ZOGENIX, INC. · on record since Sep 22, 2011
- Director at ACUSPHERE INC · on record since Oct 7, 2003
- Director at Ralliant Corp · on record since Jun 9, 2026
- Director at Fortive Corp · on record since Jun 11, 2026
- 10% owner at SeaCube Container Leasing Ltd. · on record since Jan 29, 2015
Insider trading activity of MITCHELL KATE
- Transactions on record
- 98
- since Oct 16, 2003
- Open-market buys
- 2
- $4.1M
- Open-market sells
- 16
- $4.5M
- Companies traded
- 5
- last filing Jun 11, 2026
Figures computed from official regulatory filings — methodology.
Companies where MITCHELL KATE has traded
Track record of MITCHELL KATE
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of MITCHELL KATE
Co-insiders of MITCHELL KATE
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
SCHOEMAKER KATHLEEN KALIMERA SCIENCES INC +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 11, 2026 | Award | 3,350 | 0.00 USD | $0 | SEC |
| Jun 9, 2026 | Award | 3,225 | 0.00 USD | $0 | SEC |
| Feb 19, 2026 | Sell | -7,131 | 58.34 USD | $416K | SEC |
| Feb 19, 2026 | ExerciseD | -7,131 | 0.00 USD | $0 | SEC |
| Feb 19, 2026 | Exercise | 7,131 | 29.58 USD | $210.9K | SEC |
| Feb 12, 2026 | Buy | 2,350 | 42.48 USD | $99.8K | SEC |
| Jul 2, 2025 | Award | 1,238 | 48.49 USD | $60K | SEC |
| Jul 2, 2025 | Award | 3,403 | 0.00 USD | $0 | SEC |
| Jun 4, 2025 | Award | 2,120 | 0.00 USD | $0 | SEC |
| Jun 4, 2025 | Award | 990 | 70.87 USD | $70.2K | SEC |
| Jun 4, 2025 | AwardD | 2,140 | 0.00 USD | $0 | SEC |
| Nov 12, 2024 | OtherD | -310 | 0.00 USD | $0 | SEC |
| Nov 12, 2024 | Other | -4,248 | 0.00 USD | $0 | SEC |
| Jun 5, 2024 | Award | 1,970 | 0.00 USD | $0 | SEC |
| Jun 5, 2024 | Award | 985 | 76.14 USD | $75K | SEC |
| Jun 5, 2024 | AwardD | 1,990 | 0.00 USD | $0 | SEC |
| Jun 8, 2023 | Award | 1,145 | 65.60 USD | $75.1K | SEC |
| Jun 8, 2023 | Award | 2,290 | 0.00 USD | $0 | SEC |
| Jun 8, 2023 | AwardD | 2,310 | 0.00 USD | $0 | SEC |
| Jun 8, 2022 | Award | 1,510 | 0.00 USD | $0 | SEC |
| Jun 8, 2022 | AwardD | 4,570 | 0.00 USD | $0 | SEC |
| Jun 8, 2022 | Award | 2,515 | 59.74 USD | $150.2K | SEC |
| May 4, 2022 | AwardD | 310 | 0.00 USD | $0 | SEC |
| Apr 25, 2022 | ExerciseD | -284 | 0.00 USD | $0 | SEC |
| Apr 25, 2022 | Exercise | 284 | — | — | SEC |